Infection-fighting cells in severe lung injury
Part of Infections, Lungs & breathing clinical trials.
This study looks at a type of immune cell (MAIT cell) in patients with severe lung problems caused by infections, pancreatitis, head injury, burns, or major surgery. It aims to understand how these cells change during illness, which may lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in an intensive care unit (ICU) or similar high-care unit for a severe lung infection, pancreatitis with lung failure, serious head injury, severe burns, or planned heart surgery
- You need a breathing tube (mechanical ventilation) for your lung or heart condition
- You do not have a weak immune system (like from cancer treatment, organ transplant, or certain medicines)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.
This study looks at how the immune system and ECMO (a machine that helps oxygenate blood) can improve outcomes for people with moderate to severe ARDS. If you join, researchers will monitor your condition and treatment to find better ways to manage this serious lung problem.
This study looks at how your immune system and inflammation affect your recovery in the intensive care unit. Researchers want to understand why some patients do better than others.
This trial tests a new drug called LEAF-4L6715 to see if it helps people with severe acute respiratory distress syndrome (ARDS), a serious lung condition. If you are on a breathing machine and meet the criteria below, you may be able to join.
This trial looks at how a type of white blood cell affects lung inflammation in people with severe influenza. It may help researchers find better treatments for respiratory failure caused by the flu or other infections.
This study looks at how the immune system responds in people with ARDS (a severe lung injury) and tests a new treatment called PIP-2 in the lab to see if it might help. It aims to better understand lung injury and find new ways to treat it.
Hear when a new Viral Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.